학술논문
Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial
Document Type
Article
Author
Ringshausen, Felix C; Shapiro, Adam J; Nielsen, Kim G; Mazurek, Henryk; Pifferi, Massimo; Donn, Karl H; van der Eerden, Menno M; Loebinger, Michael R; Zariwala, Maimoona A; Leigh, Margaret W; Knowles, Michael R; Ferkol, Jr, Thomas W; Brown, Trey; Carroll, Mary; Church, Nina; Couluris, Marisa; Davis, Stephanie D; Dell, Sharon D; Di Cicco, Maria E; Di Mango, Angela; Escobar, Hugo; Griffiths, Anne; Haver, Kenan; Hornick, Douglas; Johnson, Christopher; Milla, Carlos E; O'Donnell, Anne; Pink, Isabell; Pogorzelski, Andrzej; Prickett, Michelle; Raby, Benjamin A; Rosenfeld, Margaret; Saba, Thomas G; Sandvik, Rikke Mulvad; Sagel, Scott D; Salathe, Matthias; Simmons, Ashley E; Solomon, George M; Sommerburg, Olaf; Soussi, Najwa; Strausbaugh, Steven D; Sullivan, Kelli M; Werner, Claudius; Ferkol, Thomas W
Source
In The Lancet Respiratory Medicine January 2024 12(1):21-33
Subject
Language
ISSN
2213-2600